-
Immunity: control the brakes of the immune system to treat cancer and autoimmune diseases
Time of Update: 2020-02-11
February 11, 2020 / BIOON / -- immunologists of Saint Judas children's research hospital found the key biological switch to control regulatory T-cells (specialized leukocytes that control the immune s
-
The Lancet: novel coronavirus infection is more harmful than steroids in treating new coronavirus infection.
Time of Update: 2020-02-10
February 11, 2020 / BIOON / -- recently, a report was published in the lancet Novel coronavirus infection may be avoided by steroids, according to the study by scientists from University of Edinburgh
-
Nat biotechnol: capture of uncultured bacteria with specific antibodies produced by reverse genetics
Time of Update: 2020-02-08
February 8, 2020 / BIOON / - -- bacteria and archaea constitute the vast majority of the living world, but most of them, including those closely related to human beings, have never been isolated or cu
-
Blocking novel coronavirus infection: a new way of thinking: How did the virus spread from animal to human?
Time of Update: 2020-02-08
February 7, 2020 / Biovalley novel coronavirus BIOON/, with the increase in the number of deaths caused by the new coronavirus, people will naturally be worried about how far it spreads in humans Will
-
J Med Virol: novel coronavirus genome sequence characteristics revealed by the largest meta-analysis
Time of Update: 2020-02-08
The novel coronavirus (2019-nCoV) genome has been analyzed by the largest sequencing analysis in February 9, 2020 / Biovalley BIOON/ The results showed that the virus originated from bats and the hete
-
Science: crispr-cas9 editor car-t cell therapy can be used to treat refractory cancer
Time of Update: 2020-02-08
February 8, 2020 / Biovalley BIOON / -- according to the latest data released by researchers from the Abramson cancer center at the University of Pennsylvania, car-t cells edited by crispr-cas9 gene c
-
SCI Immunol: new achievements in allergy research! Brush cells in the nasal cavity may secrete pro-inflammatory lipid molecules
Time of Update: 2020-02-08
February 8, 2020 / BIOON / -- recently, a research report published in the international journal Science immunology, researchers from Brigham women's Hospital and Harvard Medical School found brush ce
-
SCI Rep: scientists have successfully isolated kidney stem cells from urine. In the future, they may develop new therapies for various kidney diseases
Time of Update: 2020-02-07
February 7, 2020 / biool / -- recently, a research report published in the international journal scientific reports, scientists from the University of Dusseldorf and other institutions have developed
-
Cancer Res: activate key proteins or effectively slow down the progression of metastatic breast cancer
Time of Update: 2020-02-07
February 7, 2020 / BIOON / -- metastasis is the main cause of cancer patients' death Currently, there is no effective treatment, so researchers urgently need to develop new treatments Recently, an int
-
NEJM: clinical trials show that CD19 car-nk cell therapy achieves a 73% remission rate in patients with leukemia and lymphoma
Time of Update: 2020-02-07
February 7, 2020 news / Biovalley BIOON / - -- in a new phase I / IIa clinical trial Researchers from the MD Anderson Cancer Center at the University of Texas reported that the treatment of CD19 targe
-
ELife: uncover the key role of camp in regulating immune response
Time of Update: 2020-02-07
February 7, 2020 / BIOON / -- recently, an international magazine published in eLife In the previous research report, scientists from the University of California revealed the key role of cyclic AMP (
-
Nat Med: antibody therapy can enhance T cell immune response in HIV infected people
Time of Update: 2020-02-07
February 7, 2020 / Biovalley BIOON / - -- most HIV infected people control the virus by taking antiretroviral drugs (Art) Despite the effectiveness of the drug, the presence of a latent HIV Library in
-
New anti-inflammatory drugs! Novartis cosentix (kesantang) us label update, into the ankylosing spondylitis (as) flexible drug delivery program!
Time of Update: 2020-02-06
February 6, 2020 / BIOON/ --Novartis recently announced that the U.S Food and Drug Administration (FDA) has approved the label update of the anti-inflammatory drug cosentix (Chinese trade name: kesant
-
Can HIV drugs be novel coronavirus infection as a "sharp weapon"?
Time of Update: 2020-02-06
February 7, 2020 / BIOON/ Novel coronavirus novel coronavirus infection was treated by anti HIV drugs two weeks ago Researchers from China have been able to fight the coronavirus infection by using a
-
Immunologist: the probability of secondary infection is very low
Time of Update: 2020-02-06
The novel coronavirus (2019-nCoV) of Wuhan has been infected by tens of thousands of people for its treatment by its super human transmission With the passage of time, more and more patients are cured
-
Novel coronavirus infection is expected to be treated with experimental antiviral drugs.
Time of Update: 2020-02-06
China novel coronavirus infection, February 7, 2020 / BIOON/, China will conduct a clinical trial in China to test the effectiveness and potential of an experimental antiviral drug against new coronav
-
Cell Rep: targeting tumor microenvironment helps to suppress cancer
Time of Update: 2020-02-06
February 5, 2020 / BIOON / -- the human immune system regulates and controls the recognition of microbial infection and the invasion of foreign bodies This natural immune response relies on important
-
Cell: strong antibody 1-18 can limit the production of HIV resistance
Time of Update: 2020-02-06
February 6, 2020 / Biovalley BIOON / - -- antiretroviral drugs (Art) is the gold standard for the treatment of HIV infection They are very effective in inhibiting the replication of the virus, but the
-
Anti inflammatory drugs! The large-scale phase III study on the treatment of psoriatic arthritis (PSA) with rinvoq, an oral inhibitor of Jak1, was successful!
Time of Update: 2020-02-06
February 6, 2020 / BIOON / -- abbvie recently announced the positive top line results of phase III select PSA study (nct03104400) of anti-inflammatory drug rinvoq (upadacitinib) in the treatment of ps
-
Science: large scale clinical trials show that HIV vaccine primary immunization enhanced immunization strategy fails
Time of Update: 2020-02-06
February 6, 2020 / Biogen / - -- another frustrating failure in the search for a vaccine that can stop HIV One of the fastest-growing HIV vaccines in human testing has failed, and a $104 million clini
